RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $499,034 | -12.7% | 76,539 | +11.2% | 0.00% | 0.0% |
| Q1 2024 | $571,530 | +352.7% | 68,859 | +500.5% | 0.00% | – |
| Q4 2023 | $126,252 | -81.5% | 11,467 | -74.8% | 0.00% | -100.0% |
| Q4 2022 | $680,666 | -54.7% | 45,560 | -32.1% | 0.00% | -50.0% |
| Q3 2022 | $1,502,000 | +30.4% | 67,130 | -2.4% | 0.00% | +100.0% |
| Q2 2022 | $1,152,000 | +426.0% | 68,790 | +648.5% | 0.00% | – |
| Q1 2022 | $219,000 | -26.8% | 9,190 | -5.7% | 0.00% | – |
| Q4 2021 | $299,000 | +13.7% | 9,746 | +16.8% | 0.00% | – |
| Q3 2021 | $263,000 | -21.3% | 8,343 | -8.5% | 0.00% | – |
| Q2 2021 | $334,000 | +34.7% | 9,119 | +27.3% | 0.00% | – |
| Q1 2021 | $248,000 | -25.7% | 7,164 | -10.9% | 0.00% | – |
| Q4 2020 | $334,000 | – | 8,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |